🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
Mineral Product Type
60% Evidence Coverage

Supplement Facts — Evidence Check

103 mg (8% DV)
✅ Within RDA (0.1× RDA of 700 mg) 📚 12 studies (Tier A: 0, B: 3)
RDA 700mg This product: 103mg UL 4000mg
10 mg (2% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 10mg
211 mg (38% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 211mg
Sodium
175 mg (8% DV)
Potassium
65 mg (1% DV)

Other Ingredients

Monosodium Phosphate Sodium Chloride Vegetable Wax Potassium Chloride Magnesium Citrate Stearic Acid Silica Magnesium Stearate Ingredients

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (89% of products) Nutrient (76% of products)

Target Groups

Adult (18 - 50 Years) Sugar Free

Product Information

📋 Directions for Use

Suggested Use: As an electrolyte replacement, take 1–3 tablets with a large glass of water one-half hour prior to physical activity that results in fluid loss. Dose depends on duration of activity and volume to fluid loss. Replace SR can also be taken after fluid loss to help restore electrolyte and fluid balance. Drink plenty of water according to thirst. Do not exceed the recommend dosage without consulting your physician or team doctor.

⚠️ Warnings & Precautions

Consult your healthcare professional prior to use if you have or suspect a medical condition, including high blood pressure, are taking any medications, are pregnant or nursing, or are sensitive to salt.

Keep out of reach of children.

Do not use if seal is broken or missing.

Do not exceed the recommend dosage without consulting your physician or team doctor.

🧪 Formulation Notes

No sugar, starch, artificial flavors, colors, sweeteners or preservatives.

Additional Information

Store in a cool, dry place.

Formulated to release electrolytes over a 4–6 hour period.

Sustained release

Electrolyte

Buffered and balanced electrolyte replacement

11620

Product Details

UPC / SKU 7 29135 11620 1
DSLD Entry Date 2018-07-25
Product Type Mineral
Form Tablet or Pill
DSLD ID 177693
Data Updated 2026-04-11

Research Evidence

46 Research Sources
55 Avg Quality Score
23 Meta Analysis
7 Systematic Review
7 Rct
4 Clinical Trial
2 Other
1 Guideline
1 Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024
View all evidence for Phosphorus →

Compare Similar Products

View all Phosphorus products →